Oxford BioMedica PLC (OXBDF)
3.86
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Oxford BioMedica Total Assets (Quarterly): 321.46M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 321.46M |
| June 30, 2023 | 505.87M |
| June 30, 2023 | 505.87M |
| December 31, 2022 | 556.91M |
| June 30, 2022 | 566.05M |
| June 30, 2022 | 566.05M |
| December 31, 2021 | 320.17M |
| June 30, 2021 | 273.60M |
| June 30, 2021 | 273.60M |
| December 31, 2020 | 250.66M |
| June 30, 2020 | 197.18M |
| June 30, 2020 | 197.18M |
| December 31, 2019 | 161.18M |
| June 30, 2019 | 163.59M |
| June 30, 2019 | 163.59M |
| December 31, 2018 | 142.62M |
| June 30, 2018 | 131.92M |
| June 30, 2018 | 131.92M |
| December 31, 2017 | 88.38M |
| June 30, 2017 | 76.40M |
| June 30, 2017 | 76.40M |
| December 31, 2016 | 69.95M |
| June 30, 2016 | 72.64M |
| June 30, 2016 | 72.64M |
| December 31, 2015 | 76.82M |
| Date | Value |
|---|---|
| June 30, 2015 | 65.15M |
| June 30, 2015 | 65.15M |
| December 31, 2014 | 52.62M |
| June 30, 2014 | 50.92M |
| June 30, 2014 | 50.92M |
| December 31, 2013 | 22.50M |
| June 30, 2013 | 28.08M |
| June 30, 2013 | 28.08M |
| December 31, 2012 | 39.47M |
| June 30, 2012 | 32.95M |
| June 30, 2012 | 32.95M |
| December 31, 2011 | 40.21M |
| June 30, 2011 | 53.90M |
| December 31, 2010 | 39.58M |
| June 30, 2010 | 54.01M |
| December 31, 2009 | 71.07M |
| June 30, 2009 | 88.34M |
| December 31, 2008 | 63.16M |
| June 30, 2008 | 111.80M |
| December 31, 2007 | 121.47M |
| June 30, 2007 | 130.20M |
| December 31, 2006 | 69.60M |
| June 30, 2006 | 83.08M |
| December 31, 2005 | 84.68M |
| June 30, 2005 | 44.35M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
161.18M
Minimum
Dec 2019
566.05M
Maximum
Jun 2022
334.86M
Average
273.60M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 258.01M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| Verona Pharma PLC | 289.91M |
| NuCana PLC | 35.43M |
| Autolus Therapeutics PLC | 375.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 222.31M |
| Shareholders Equity (Quarterly) | 94.28M |
| Debt to Equity Ratio | 0.5207 |
| Current Ratio | 3.189 |
| Net Debt Paydown Yield | 4.34% |